Albot G
Ann Gastroenterol Hepatol (Paris). 1985 May 28;21(2 Pt 2):17-20.
After reviewing its mechanism of action, the author summarises the action of Primperan in gastro-oesophageal reflux. Various studies have shown that the intravenous or oral administration of a single dose of Primperan induces an increase in the tone of the inferior oesophageal sphincter and an acceleration of gastric emptying in patients with gastro-oesophageal reflux. A dose of at least 10 mg is required. Long term Primperan treatment, at a dose of 40 mg/day in 4 doses, before each meal and at bedtime, significantly reduces the symptoms of gastro-oesophageal reflux and the consumption of antacids.
在回顾了其作用机制后,作者总结了普瑞博思在胃食管反流中的作用。各种研究表明,对胃食管反流患者静脉注射或口服单剂量普瑞博思可使食管下括约肌张力增加,并加速胃排空。所需剂量至少为10毫克。长期以每日40毫克、分4次、在每餐饭前及睡前服用的剂量进行普瑞博思治疗,可显著减轻胃食管反流症状并减少抗酸剂的用量。